Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 4, 2008

View Archived Issues

Amitriptyline beneficial in benign prostatic hyperplasia

AstraZeneca develops 5-HT1B receptor radioligand for PET imaging

Notch inhibition with MRK-003 active in preclinical pancreatic cancer experiments

Recent GSK, Pfizer and Roche patents disclose new antipsychotic agents

Novel therapeutic agents for respiratory and allergic disorders described in recent patents

Recent Bayer and Takeda patents disclose novel compounds for cardiovascular disorders

Snapshots: Recent data on immunoconjugates from ImmunoGen

Interim results from a phase I solid tumor study with weekly EZN-2968

GlaxoSmithKline: Q3 review

FDA accepts IND for ART-621, Arana to commence phase II studies

PAION reports successful meta-analysis for pain drug M6G

Synosia starts phase IIa nepicastat trial in post-traumatic stress disorder

TMC-207 shows promise as a treatment for tuberculosis

FDA approves donated blood screening test for HIV, HCV and HBV

FDA approves Treanda for relapsed indolent non-Hodgkin's lymphoma

Mpex initiates phase II clinical trial of aerosol MP-376 in COPD

Neoprobe receives positive EMEA response to RIGScan CR submission

ProStrakan launches Sancuso in U.S. for chemotherapy-induced nausea

Welichem reports phase IIa results for WBI-1001 atopic dermatitis cream

BioMarin commences clinical assessment program for Morquio A syndrome

MedImmune commences phase I/IIa trial for respiratory syncytial virus vaccine

Portola starts phase II betrixaban trial for stroke prevention in atrial fibrillation

Medarex and MBL report results from phase II trial of MDX-066 and MDX-1388

AEterna Zentaris initiates second stage of patient recruitment in phase II trial of AEZS-108

Canopus reports results from specialized laboratory study of peptide cancer vaccine

Cel-Sci expands licensing agreement for cancer drug Multikine to Orient Europharma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...